SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001520138-22-000388
Filing Date
2022-08-31
Accepted
2022-08-31 17:15:23
Documents
15
Period of Report
2022-08-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT bivi-20220831_8k.htm   iXBRL 8-K 38901
2 EXHIBIT 1.1 bivi-20220831_8kex1z1.htm EX-1.1 266491
3 EXHIBIT 5.1 bivi-20220831_8kex5z1.htm EX-5.1 14980
7 GRAPHIC image_001.jpg GRAPHIC 10444
  Complete submission text file 0001520138-22-000388.txt   576326

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bivi-20220831.xsd EX-101.SCH 2971
5 XBRL LABEL FILE bivi-20220831_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE bivi-20220831_pre.xml EX-101.PRE 22367
9 EXTRACTED XBRL INSTANCE DOCUMENT bivi-20220831_8k_htm.xml XML 3599
Mailing Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703
Business Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703 775-888-3162
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

IRS No.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39015 | Film No.: 221218735
SIC: 2834 Pharmaceutical Preparations